financetom
Business
financetom
/
Business
/
Silgan Holdings' Q1 Adjusted Earnings, Net Sales Fall; Q2 EPS Outlook Issued, 2024 Adjusted EPS Guidance Affirmed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Silgan Holdings' Q1 Adjusted Earnings, Net Sales Fall; Q2 EPS Outlook Issued, 2024 Adjusted EPS Guidance Affirmed
May 1, 2024 6:39 AM

09:15 AM EDT, 05/01/2024 (MT Newswires) -- Silgan Holdings ( SLGN ) reported Q1 adjusted earnings Wednesday of $0.69 per diluted share, down from $0.78 a year earlier.

Analysts polled by Capital IQ expected $0.66.

Net sales for the quarter ended March 31 were $1.32 billion, down from $1.42 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.37 billion.

For Q2, the company said it expects adjusted earnings of $0.82 to $0.92 per diluted share. Analysts polled by Capital IQ expect $0.88.

The company said it continues to expect 2024 adjusted earnings of $3.55 to $3.75 per diluted share. Analysts surveyed by Capital IQ expect $3.66.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Onex Partners Completes Acquisition of Accredited
Onex Partners Completes Acquisition of Accredited
Jun 28, 2024
10:30 AM EDT, 06/28/2024 (MT Newswires) -- Onex Partners (ONEX.TO) said Friday it has completed its acquisition of Accredited, a global P&C program manager. A statement noted Accredited will now operate as an independent program management company providing A- rated (AM Best) insurance capacity in Europe, the UK and the US. Accredited writes more than $2.1 billion of gross premium...
Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment
Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment
Jun 28, 2024
10:34 AM EDT, 06/28/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Friday that it has submitted a new drug application for chenodiol for treating patients with cerebrotendinous xanthomatosis, or CTX, in the US. CTX is a rare progressive disorder of cholesterol metabolism that can affect the brain, spinal cord, tendons, eyes, and arteries, the company said. The submission...
What's Going On With Palantir Technologies Shares Today?
What's Going On With Palantir Technologies Shares Today?
Jun 28, 2024
Palantir Technologies Inc. ( PLTR ) shares are trading marginally higher on Friday. Peter Thiel, Chairman of Palantir Technologies ( PLTR ), shared his outlook on the future in an NBC News interview. He focused on AI, digital currencies, and his views on America’s current state. In an interview with BNN Bloomberg, Dan Ives, an analyst at Wedbush Securities, dismissed the notion...
Lake Resources cuts staff, eyes asset sales amid low lithium prices
Lake Resources cuts staff, eyes asset sales amid low lithium prices
Jun 28, 2024
LAS VEGAS, June 27 (Reuters) - Lithium developer Lake Resources is laying off staff and selling assets as low prices for the electric vehicle battery metal hamper efforts to find customers and investors for its flagship Kachi project in Argentina, its CEO said. The move is the latest blow to the lithium industry and its struggling producers after the more...
Copyright 2023-2026 - www.financetom.com All Rights Reserved